Company Overview
Generating analyst summary…
Log in to access full profile ›Company Intelligence Q&A
- What is Cuspa's core product?
- Cuspa's core product is CUSPER, an artificial cusp designed for the transcatheter treatment of aortic valve insufficiency. It attaches to the native aortic valve cusp using a nitinol grasper to restore proper valve function.
- When was Cuspa founded?
- Cuspa was founded in August 2019 by Yair Feld.
- What is Cuspa's current product development stage?
- Cuspa's CUSPER device is currently in the clinical trial stage, with pre-clinical studies on pigs having been carried out to optimize its performance.
- What is the primary medical condition Cuspa aims to address?
- Cuspa aims to treat aortic valve insufficiency (AI), a heart disorder where the aortic valve does not close properly, causing blood to flow backward into the heart.